Author:
Wang Yi,Chen Kai,Cai Yihong,Cai Yuanxia,Yuan Xiaojun,Wang Lifeng,Wu Zhixiang,Wu Yeming
Funder
National Natural Science Foundation of China
Shanghai Rising-Star Program
Publisher
Springer Science and Business Media LLC
Reference58 articles.
1. Maris JM, Hogarty MD, Bagatell R, Cohn SL. Neuroblastoma. Lancet. 2007;369:2106–20.
2. Izbicki T, Mazur J, Izbicka E. Epidemiology and etiology of neuroblastoma: an overview. Anticancer Res. 2003;23:755–60.
3. Spix C, Pastore G, Sankila R, Stiller CA, Steliarova-Foucher E. Neuroblastoma incidence and survival in European children (1978-1997): report from the automated childhood cancer information system project. Eur J Cancer. 2006;42:2081–91.
4. Maris JM. Recent advances in neuroblastoma. N Engl J Med. 2010;362:2202–11.
5. Keshelava N, Zuo JJ, Chen P, Waidyaratne SN, Luna MC, Gomer CJ, et al. Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines. Cancer Res. 2001;61:6185–93.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献